Related Experiment Video
Updated: Sep 15, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Factors Influencing Oxalate Synthesis in Healthy Volunteers
Sonia Fargue1, John Knight1, Naim M Maalouf2
1Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Endogenous oxalate synthesis (EOS), a key factor in kidney stone risk, is primarily driven by lean body mass, not body fat. Oxalate production differs between males and females, even when accounting for lean mass.
Area of Science:
- Biochemistry
- Nephrology
- Human Physiology
Background:
- Urine oxalate excretion is a risk factor for calcium oxalate kidney stone formation.
- Urine oxalate originates from dietary absorption and endogenous oxalate synthesis (EOS).
- Previous studies suggest a positive correlation between urine oxalate, body mass index (BMI), and body weight.
Purpose of the Study:
- To investigate the association between endogenous oxalate synthesis (EOS) and body size/composition.
- To estimate EOS by measuring urinary oxalate during an ultra-low oxalate diet.
Main Methods:
- Analysis of prospectively collected data from 88 healthy adults on ultra-low oxalate diets.
- Measurements included anthropometrics, body composition (bioelectrical impedance analysis), and urinary oxalate (ion chromatography-mass spectrometry).
- Exclusion criteria: history of kidney stones, hypertension, or diabetes.
Main Results:
- Urinary oxalate positively correlated with body weight, BMI, lean body muscle mass, appendicular lean muscle mass, waist-to-hip ratio, and urinary creatinine.
- No significant correlation was found between urinary oxalate and body fat or age.
- Urinary oxalate excretion differed between males and females, independent of lean body composition.
Conclusions:
- Lean body mass, rather than body fat, is the primary determinant of endogenous oxalate synthesis (EOS).
- Oxalate synthesis within lean body compartments exhibits sexual dimorphism.
- Findings suggest potential sex-specific strategies for managing oxalate metabolism and kidney stone risk.
More Related Videos
14:12HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2’-deoxyguanosine, in Cultured Cells and Animal Tissues
Published on: August 1, 2015
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Related Concept Videos
Factors Influencing Drug Absorption: Anatomical Parameters
Factors Influencing Bioavailability: First-Pass Elimination
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Influencing Drug Absorption: Presystemic Elimination